Trial Profile

A Double-Blind, Randomized, Placebo-Controlled Trial Evaluating The Safety And Efficacy Of Early Treatment With Eplerenone In Patients With Acute Myocardial Infarction

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 29 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Eplerenone (Primary)
Indications Cardiovascular disorders; Myocardial infarction
Focus Therapeutic Use
Acronyms REMINDER
Sponsors Pfizer

Most Recent Events

29 Apr 2014 Results published in the European Heart Journal.
11 Mar 2013 Results summarised in a media release from the American College of Cardiology.
11 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology. Additional information incorporated from slides presented at the conference.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com